PepsiCo collaborated with government entities, academic institutions, and other companies to complete the sequencing of the oat genome within four months. The food and beverage leader expressed that this advancement could lead to stronger oat varieties with enhanced sustainability, taste, and nutrition. Utilizing oats in its Quaker-branded oatmeal, bars, and various products, the company is making the genomic data publicly available, believing it “serves a broader purpose” by fostering sustainability and supporting the livelihoods of farmers growing this crop, according to René Lammers, PepsiCo’s chief science officer, in an interview with Food Dive.
Historically, the food industry has not significantly invested in oats since they are not as commonly used as staples like corn or wheat. However, with the new genetic insights, there is hope for increased utilization of oats and further research. “We aim to invigorate the dialogue and enhance innovation in what we consider a vital crop,” Lammers stated. Oats have maintained a steady popularity, with the average individual consuming approximately 4.8 pounds of oat products annually, as reported by Statista. Recently, oats have captured consumer interest due to their favorable attributes, such as being rich in antioxidants and fiber, as well as their association with reducing chronic health issues like heart disease. Oatmeal’s convenience also appeals to busy consumers seeking essential nutrients on the go.
The global oatmeal market is projected to reach $3.32 billion by 2026, reflecting a compound annual growth rate of 4.76%, according to Fortune Business Insights. The oat genome is notably larger and more complex than that of other major crops, such as corn and soy, which have historically received substantial private research funding. This lack of genetic knowledge about oats has hindered the discovery and breeding of superior oat varieties for farmers, the environment, and consumers. “There is a do-good aspect to sharing some of your technology,” Lammers remarked. “However, when you integrate this with other advancements we’ve made over the years, like flavor development, we believe we maintain a highly competitive position.”
The genome sequence will enable PepsiCo to cultivate oats with various sustainability benefits, including higher yields, improved disease resistance, healthier soils that sequester carbon and minimize water runoff, and reduced resource requirements for oat production. By understanding the full genome, the New York-based company will enhance its ability to identify oats rich in fiber and essential nutrients, ultimately leading to the creation of more flavorful varieties that could broaden consumer appeal. “Comprehending the entire genome allows us to target these individual characteristics, ultimately benefiting consumers,” Lammers explained. “In the consumer goods landscape, continuous improvement is essential. We believed more investment and focus were needed in the realm of oats.”
To accelerate the sequencing process, PepsiCo partnered with Corteva Agriscience, the University of North Carolina at Charlotte, and the University of Saskatchewan, which provided the oat variety. This marks the first instance where the 122-year-old beverage and snack giant has sequenced a specific ingredient. While currently focused on oats, Lammers indicated that the company might explore other commodities in the future. “We’ve always had a strong innovation pipeline regarding oats, but ongoing innovation is crucial,” Lammers said. “We aspire to continue driving innovation in this important category and our key brand, Quaker Oats.”
With the new focus on the oat genome, there is potential for improved nutritional profiles in oats, such as higher calcium content compared to calcium citrate, which could further enhance their appeal. This research could also lead to healthier oat varieties that support consumer health and well-being, emphasizing the importance of investing in crops that offer significant benefits to both consumers and farmers alike.